Korea designates 2 'urgently-needed medical devices' for dialysis of babies

South Korea designated two device groups as scarce or urgently needed medical supplies. The first is the PD Catheter, developed by U.S.-based Merit Medical. The second is the Dialy-Nate Set and Dialy-Nate Catheter, made by Utah Medical Products.

These devices are used for peritoneal dialysis. In this treatment, cleansing fluid flows through a catheter into the abdomen. The fluid collects waste from the blood and then leaves the abdomen, carrying the filtered waste with it.

The designation targets a serious treatment gap for very young patients. Officials said kidney-failure treatment is especially important for newborns and young children because delays carry a high risk of death. The devices also help address the need for suitable catheter sizes and accurate control of dialysis fluid. Their designation simplifies import procedures in Korea.

Peritoneal dialysis is a method for removing waste from a patient’s blood. It uses the abdomen as the treatment space and requires a tube, or catheter, to move cleansing fluid in and out. The process matters because it provides a way to treat kidney failure when the kidneys cannot adequately remove waste.

The key mechanism is a repeated fluid exchange. Cleansing fluid flows through the catheter into the abdomen. Waste moves from the blood into that fluid. The fluid, now containing filtered waste, then flows back out of the abdomen through the tube.

The South Korean government designated two catheter-related device groups for this purpose. They are intended to improve dialysis treatment for newborns and young children. Officials stressed that the catheter must be appropriately sized and the dialysis fluid must be controlled precisely, especially for these vulnerable patients.

Newborns and young children need dialysis equipment that matches their smaller bodies. Officials said using a size-appropriate catheter is crucial. They also stressed precise control of the dialysis fluid. These requirements matter because kidney-failure treatment is especially urgent in this age group.

A catheter delivers cleansing fluid into the abdomen and removes it afterward. If the device is not suited to the patient’s size, the treatment may not be appropriately matched to that child. The amount and movement of fluid must also be controlled during the exchange. The article identifies both requirements as central to safer, more suitable care.

The stakes are high. Officials said any delay in treating kidney failure in newborns and young patients carries a high risk of death. South Korea’s designation is intended to improve access to devices that meet these needs and support timely peritoneal dialysis.

A total of 43 medical devices have received South Korea’s designation as scarce or urgently needed supplies. The category is reserved for devices considered essential to treating rare or intractable diseases and unavailable from a substitute in the domestic market.

The two newly designated device groups are the PD Catheter from Merit Medical and the Dialy-Nate Set and Dialy-Nate Catheter from Utah Medical Products. They are used in peritoneal dialysis, which moves cleansing fluid through a tube into the abdomen to remove waste from blood.

The figure shows that the designation is part of a broader Korean system, not a one-time decision for these products. Once designated, devices receive a greatly simplified import process, including authorization, certification, and reports. That can help make essential equipment available more efficiently for patients who need it.

After a device receives South Korea’s scarce or urgently needed designation, its import process becomes greatly simpler. The change covers authorization, certification, and reports connected with bringing the device into the country.

This matters because the designated products are considered crucial medical supplies. They are essential for treating rare or intractable diseases and have no substitute in the domestic market. In this case, the devices support peritoneal dialysis for newborns and young children, for whom treatment delays can carry a high risk of death.

The simplified process is meant to improve access rather than change how dialysis works. The PD Catheter and Dialy-Nate devices still deliver or remove cleansing fluid through a tube in the abdomen. However, easier import procedures can help make these size-appropriate and fluid-control devices available more efficiently in South Korea.

The devices come from two U.S.-based companies. Merit Medical developed the PD Catheter. Utah Medical Products developed the Dialy-Nate Set and Dialy-Nate Catheter. Both device groups are used for peritoneal dialysis in newborns and young children.

The South Korean Ministry of Food and Drug Safety identified the devices as scarce or urgently needed medical supplies. Its designation reflects the devices’ importance for treating rare or intractable diseases and the absence of a domestic substitute. The ministry’s announcement also established their place within South Korea’s medical-supply system.

The designation has a practical effect. Import procedures for the devices, including authorization, certification, and reports, are greatly simplified. That action supports access to equipment needed for size-appropriate catheter use and precise dialysis-fluid control, both of which officials said are crucial for young patients receiving treatment.

Kidney failure is a condition in which the kidneys do not adequately remove waste from the blood. The article connects this problem with the need for dialysis, a treatment that uses cleansing fluid to remove waste. This explanation draws on the article’s description of dialysis and the established medical meaning of kidney failure.

In peritoneal dialysis, fluid flows through a tube into the abdomen. Waste passes from the blood into the fluid, which then flows out carrying the filtered waste. Catheters must be appropriately sized, and the fluid must be controlled precisely, especially for newborns and young children.

The danger is greatest when treatment is delayed. South Korean officials said kidney-failure treatment is especially crucial for newborns and young patients because any delay has a high risk of death. The device designation is intended to improve access to suitable dialysis equipment.